# The Effects of ECMO on the Pharmacokinetics of Hydromorphone

> **NCT05565495** · PHASE2 · RECRUITING · sponsor: **Xiaobo Yang, MD** · enrollment: 26 (estimated)

## Conditions studied

- Extracorporeal Membrane Oxygenation

## Interventions

- **DRUG:** Hydromorphone

## Key facts

- **NCT ID:** NCT05565495
- **Lead sponsor:** Xiaobo Yang, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05565495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05565495, "The Effects of ECMO on the Pharmacokinetics of Hydromorphone". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05565495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*